CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Roche Holding AG (Participation) - ROGz CFD

245.6
0.61%
Market Trading Hours* (UTC) Opens on Tuesday at 07:00

Mon - Fri: 07:00 - 15:20

  • Summary
  • Historical Data
Trading сonditions
Spread 1.0
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.014984 %
Charges from full value of position ($-2.85)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.014984%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.007238 %
Charges from full value of position ($-1.38)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.007238%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency CHF
Margin 5%
Stock exchange Switzerland
Commission on trade 0%

Key Stats
Prev. Close 247.1
Open 245.5
1-Year Change -12.16%
Day's Range 243.2 - 245.9
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jun 17, 2024 245.6 -0.4 -0.16% 246.0 246.5 243.0
Jun 14, 2024 247.1 0.6 0.24% 246.5 248.1 245.3
Jun 13, 2024 245.3 2.2 0.90% 243.1 245.5 242.1
Jun 12, 2024 242.5 2.4 1.00% 240.1 243.0 239.6
Jun 11, 2024 240.9 1.7 0.71% 239.2 241.1 238.5
Jun 10, 2024 239.5 0.5 0.21% 239.0 242.1 238.1
Jun 7, 2024 241.9 3.6 1.51% 238.3 243.5 238.2
Jun 6, 2024 238.0 2.2 0.93% 235.8 238.6 235.1
Jun 5, 2024 236.0 1.1 0.47% 234.9 237.3 234.5
Jun 4, 2024 233.8 1.9 0.82% 231.9 235.1 231.8
Jun 3, 2024 231.2 -0.7 -0.30% 231.9 232.8 230.1
May 31, 2024 231.4 3.6 1.58% 227.8 231.5 226.7
May 30, 2024 227.7 1.9 0.84% 225.8 228.2 225.8
May 29, 2024 229.1 1.3 0.57% 227.8 230.7 226.1
May 28, 2024 228.2 -1.9 -0.83% 230.1 231.2 227.9
May 27, 2024 228.6 -1.0 -0.44% 229.6 230.7 228.6
May 24, 2024 230.1 -1.3 -0.56% 231.4 232.0 229.7
May 23, 2024 231.6 -0.5 -0.22% 232.1 234.4 231.5
May 22, 2024 230.8 -3.8 -1.62% 234.6 235.0 230.6
May 21, 2024 235.1 -2.8 -1.18% 237.9 238.1 234.8

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Roche Company profile

About Roche Holding AG

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Roche Holding AG revenues increased 8% to SF62.8B. Net income decreased 3% to SF13.93B. Revenues reflect Diagnostics segment increase of 29% to SF17.76B, Chugai segment increase of 20% to SF4.51B, Rest of Europe segment increase of 16% to SF11.38B, Rest of Asia segment increase of 13% to SF9.75B, Germany segment increase of 29% to SF4.29B.

Equity composition

3 April 2001, 100 for 1 stock split.

Industry: Pharmaceuticals (NEC)

Grenzacherstrasse 124
BASEL
BASEL-STADT 4058
CH

News

RBA Meeting Preview: No change to policy expected, markets look for fresh guidance

The Reserve Bank of Australia is expected to keep interest rates unchanged at 4.35% when it meets on Tuesday, June 18th, 2024, at 2:30 PM (AEST).

13:17, 17 June 2024

FOMC Decision Review: Rates unchanged as central bank raises inflation and interest rate forecasts

The FOMC left Federal Funds Rate unchanged at a target range of 5.25 to 5.50%.

10:55, 17 June 2024

Bank of Japan Preview: Markets look for guidance from BOJ about timing of next hike

The Bank of Japan meets on Friday, 14th of June, 2024. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

11:05, 12 June 2024

FOMC preview: Still expecting three rate cuts in 2024?

The Federal Reserve is expected to keep its policy unchanged on Wednesday – data from Reuters shows a 99% chance of no change. Last week’s 25-basis-point rate cut from the ECB has done nothing to change market expectations, and why should it?

08:20, 11 June 2024

US Non-Farm Payrolls Preview: Forecasts point to a stable labour market

US labour market conditions are expected to have remained stable in May. The latest Non-Farm Payrolls data will be released on Friday, June 7th, 2024, and will provide a health check on the US jobs market.

10:09, 5 June 2024

AUD/USD analysis: Focus turns to GDP data after unexpected CPI rise

Higher-than-expected monthly CPI data watered down expectations for RBA interest rate cuts in 2024; the markets will now shift attention to quarterly GDP data on Wednesday, June 5.

15:57, 4 June 2024

ECB preview: A cut, but how many more?

After months of waiting, a rate cut from the ECB on Thursday looks like a done deal. Data from Reuters shows markets pricing in a 96% chance of a 25-basis point cut from the European Central Bank following Thursday’s policy meeting.

08:54, 4 June 2024

People also watch

US100

19,904.90 Price
+1.140% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

65,400.00 Price
-1.630% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.50 Price
+0.040% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

3,426.62 Price
-4.810% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 620,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading